(₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
---|---|---|---|---|---|
Total Income | 181.82 | 122.78 | 112.16 | 48.1% | 62.1% |
Total Expenses | 142.06 | 128.28 | 119.64 | 10.7% | 18.7% |
Profit Before Tax | 39.77 | -5.50 | 53.10 | -823.1% | -25.1% |
Tax | 2.23 | 0.00 | 0.00 | - | - |
Profit After Tax | 37.54 | -5.50 | 53.10 | -782.5% | -29.3% |
Earnings Per Share | 6.90 | -1.00 | 9.80 | -790.0% | -29.6% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Ind-Swift Ltd is a company primarily involved in the pharmaceutical industry. It engages in the development, manufacturing, and marketing of various pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company caters to both domestic and international markets, providing a diverse range of healthcare products. As of the information available, significant recent developments are not specified, and further details about the company's strategic initiatives or market expansions are not available.
In the quarter ending Q4FY25, Ind-Swift Ltd reported a total income of ₹181.82 crores, marking a significant increase of 48.1% from the previous quarter (Q3FY25), where the income was ₹122.78 crores. Compared to the same quarter in the previous year (Q4FY24), the total income increased by 62.1%, rising from ₹112.16 crores. This indicates a substantial year-over-year and quarter-over-quarter growth in revenue, suggesting strong sales performance for the period. The increase in revenue reflects the company's capacity to expand its operations and capture a larger market share over the past year.
Ind-Swift Ltd's profitability metrics indicate fluctuations across different quarters. The Profit Before Tax (PBT) for Q4FY25 was ₹39.77 crores, a significant turnaround from a loss of ₹5.50 crores in Q3FY25, representing a quarter-over-quarter change of -823.1%. However, when compared to Q4FY24, where the PBT was ₹53.10 crores, there is a decrease of 25.1% year-over-year. The Profit After Tax (PAT) for Q4FY25 stood at ₹37.54 crores, contrasting sharply with the loss of ₹5.50 crores in the preceding quarter, reflecting a -782.5% change. Year-over-year, PAT decreased by 29.3% from ₹53.10 crores in Q4FY24. These figures illustrate volatility in profitability, with notable improvement from the previous quarter despite a decline compared to the same quarter last year.
The operating metrics for Ind-Swift Ltd reveal key insights into the company's performance. Total expenses for Q4FY25 amounted to ₹142.06 crores, increasing by 10.7% from ₹128.28 crores in Q3FY25 and by 18.7% from ₹119.64 crores in Q4FY24. This rise in expenses may correlate with increased operational activities or cost factors in the reported period. Furthermore, the Earnings Per Share (EPS) for Q4FY25 was ₹6.90, a recovery from the negative ₹1.00 in Q3FY25, indicating a quarter-over-quarter change of -790.0%. Nevertheless, there was a decline by 29.6% compared to the EPS of ₹9.80 in Q4FY24. These metrics demonstrate a recovery in operational performance from the previous quarter, yet a year-over-year comparison shows a decrease in earnings efficiency.